Colon cancer is currently staged with Ct. however, mRi is superior in the detection of colorectal liver metastasis, and mRi is standard in local staging of rectal cancer. optimal (local) staging of colon cancer could become crucial in selecting patients for neoadjuvant treatment in the near future (fluoropyrimidine oxaliplatin and targeted Receptor Preoperative therapy trial).
D
istant and local staging of colon cancer is currently mainly performed with Ct. however, according to a recent meta-analysis, Ct has a limited sensitivity of 75% for detecting liver metastasis. 1 at diagnosis, 15% to 23% of patients with colorectal cancer have liver metastasis. 2, 3 Detection is crucial because it means poor prognosis and a different clinical approach and treatment. 4 multiple studies already demonstrated that mRi is superior to Ct for the detection of liver metastasis. 1, 5 Both the introduction of diffusion-weighted imaging (DWi) and the use of liver-specific hepatobiliary contrast agents have contributed to the superior results of mRi in detecting small liver lesions. 6, 7 unlike in rectal cancer where local staging with imaging is crucial to determine the proper (neoadjuvant) treatment strategy, imaging in colon cancer is mostly used as a surgical roadmap. however, the role of imaging for local staging of colon cancer might emerge in the near future; several small studies and case reports have shown additional value of neoadjuvant treatment in locally advanced colon cancer. [8] [9] [10] [11] [12] furthermore, a large multicenter study, fluoropyrimidine oxaliplatin and targeted Receptor Preoperative therapy (foXtRot), 13 is currently investigating the benefits of neoadjuvant chemotherapy for patients with locally advanced colon cancer. if the foXtRot trial confirms initial promising reports, neoadjuvant treatment in patients with colon cancer will be adopted as standard therapy, just like in patients with rectal cancer. if so, preoperative imaging will become a crucial tool to select patients for neoadjuvant treatment. in the foXtRot trial, Ct is used to detect locally advanced colon cancer and, thus, eligibility for neoadjuvant treatment. nonetheless, a recent meta-analysis 14 showed disappointing results for staging colon cancer with Ct. in our opinion, this means that other modalities, such as mRi, should at least be considered. mRi is well established in local staging of rectal cancer because of its superior results compared with Ct. 15 however, little is known about the local staging of colon cancer with mRi. if mRi is able to accurately stage colon tumors, it might be the ideal imaging tool for simultaneous local and distant staging. therefore, the aim of this study was to evaluate the diagnostic performance of mRi for local staging of patients with colon cancer.
PATIENTS AND METhODS
this study was approved by the institutional review board. informed consent was waived because of the retrospective nature of the study.
Patient
Population eighty consecutive patients were diagnosed with colon cancer at our institution from april 2014 until may 2015. inclusion criteria were as follows: 1) biopsy-proven adenocarcinoma of the colon (with a distal tumor margin >15 cm from the anorectal junction, measured at endoscopy), 2) preoperative staging with mRi, and 3) availability of histopathological results after surgical resection of the colon. twenty-five patients were excluded for the following reasons: no surgical resection (only a polypectomy with tumor-free margin was performed during colonoscopy, n = 11), inoperable disease (n = 8), benign outcome (eg, adenoma; these patients received an mRi before the definitive histopathological result was available) at histopathology (n = 5), and insufficient mRi quality because of severe motion artefacts (n = 1). this left a total of 55 patients who met the final inclusion criteria.
MRI Protocol
imaging was performed with a 1.5-tesla mRi (ingenia, Philips medical systems, Best, the netherlands) using a phased array body coil. Patients were placed in feetfirst supine position. Bowel preparation consisted of ≥3 hours of fasting before the magnetic resonance (mR) examination. to minimize peristaltic movements, patients received an intravenous bolus injection before the mR examination consisting of 20 mg of hyoscine butylbromide (Buscopan, Boehringer ingelheim BV, ingelheim, Germany) before the start of the examination or 1 mg of glucagon (GlucaGen, novo nordisk, Bagsvaerd, Denmark) in case of a contraindication to receive hyoscine butylbromide. the scan protocol consisted of a mR liver protocol combined with an additional mR colon protocol covering the whole abdomen. this additional colon protocol consisted of t2-weighted turbo spin echo sequences (2 axial stacks and 1 coronal stack), an axial diffusion-weighted sequence (acquired in 3 stacks; b1000 being the highest b value), and a precontrast and postcontrast t1 thrive sequence (in coronal plane). the echo times and repetition times were 80 and 5596 ms for t2 and 65 and 3808 ms for DWi. the section thicknesses for t2 and DWi were 3 and 8 mm. the minimal section gaps for t2 and DWi were 3 and 0 mm. field of views were 390 × 390 mm for t2 and 380 × 290 mm for DWi. acquisition matrices for the t2 and DWi were 392 × 392 and 152 × 115 with acquisition voxel sizes (in millimeters) of 0.99 × 0.99 × 3.00 and 2.50 × 2.51 × 8.00. the numbers of excitations were 2 for t2 and 4 for DWi. acquisition time of the mR colon protocol was 18 minutes. total acquisition time of the colon and liver protocol was 50 minutes.
Image Evaluation two readers (reader 1 with 12 y and reader 2 with 8 y of experience in reading abdominal mRis) independently assessed the mR colon images to evaluate the local tumor status. the liver images were used for additional clinical staging of distant metastases (outside the scope of this study). the readers were blinded for the surgical outcome and histological results. Both readers scored the following items: 1) location of the tumor (caecum, ascending colon, transverse colon, descending colon, and sigmoid); 2) tumor stage (t1-2 vs t3-4); 3) in case of a t3 or t4 tumor, the depth of extramural invasion (emD) of ≤5 mm classified as a t3ab tumor and an emD of >5 mm classified as a t3cd tumor; 4) in case of a t4 tumor, the presence of serosal involvement and/or adjacent organ invasion; 5) extramural venous invasion (emVi); and 6) lymph nodes status (n0/n+). the readers evaluated the above-mentioned items by use of a confidence level score (0 = definitely not, 1 = probably not, 2 = uncertain, 3 = probably yes, 4 = definitely yes). all of the imaging data sets (t2-weighted, DWi, nonenhanced, and contrast-enhanced thrive) were at the readers' disposal.
Image Assessment Criteria the criteria used for determining the t stage were based on the American Joint Committee on Cancer fifth TNM classification, because this edition is still used in the netherlands and other European countries (eg, United Kingdom). for positive nodal involvement, the criteria were a short axis diameter of ≥8 mm and/or a cluster of 3 or more lymph nodes with a short axis diameter of >5 mm. EMVI was defined as direct invasion of the tumor in a vascular structure, serpiginous vessels, and/or an irregular aspect of the vessel wall near the tumor site. 16 
Statistical Analyses
Descriptive statistics were used for the assessment of baseline characteristics. for diagnostic performance, the following outcomes were evaluated: t stage (t1/t2 vs t3/t4 and t1-t3ab vs t3cd/t4), serosal involvement, emVi, and nodal involvement. the diagnostic performance of mRi for the above-mentioned outcomes was evaluated by means of receiver operator characteristics curves for which areas under the receiver operator characteristics curve (auC) with 95% Cis were calculated. sensitivity and specificity with 95% Cis were calculated by 2 × 2 contingency tables based on the confidence level scores. Cutoff for confidence level scores was set between 2 and 3 before onset of the study. analyses were performed with sPss software version 22.0 (iBm Corp., armonk, nY). interobserver agreement was compared using quadratic weighted κ statistics and was categorized as poor, fair, moderate, good, and very good agreement according to κ values <0.20, 0.21 to 0.40, 0.41 to 0.60, 0.61 to 0.80, and 0.81 to 1.00.
Reference Standard surgery was performed using standard techniques. 17 the resected specimens were processed using standard histologic protocol. 18 all of the specimens were evaluated by a senior pathologist with 10 years of experience in Gi pathology.
RESULTS

Patient and Tumor Characteristics
the final study population consisted of 55 patients (23 women and 32 men) with a median age of 69 years (range, 34-84 y). on average, surgery was performed 22 days (range, 3-51 d) after the staging mRi. in 50 of 55 patients, 12 or more lymph nodes were harvested. in 5 patients, less than 12 lymph nodes were harvested, with a minimum of 6 resected lymph nodes. a tumor-free resection margin (ie, R0 resection) was achieved in all of the included patients. Detailed tumor characteristics are given in 
Tumor Location
Both readers correctly identified the location of the tumor in each patient. ten tumors were located in the caecum, 15 in the ascending colon, 3 in the transverse colon, 7 in the descending colon, and 20 in the sigmoid. interobserver agreement between both readers was perfect (κ = 1.0).
Tumor Stage auC for differentiating between t1 to t2 and t3 to t4 tumors was 0.88 (95% Ci, 0.77-0.99) for reader 1 and 0.85 (95% Ci, 0.74-0.96) for reader 2. the sensitivity and specificity for detecting t3 to t4 tumors were 91% (95% Ci, 76%-98%)/84% (95% Ci, 60%-96%) for reader 1 and 72% (95% Ci, 50%-87%)/89% (95% Ci, 65%-98%) for reader 2. in patients with a t3 tumor, the sensitivity and specificity for detecting t3cd/ t4 tumors were 40% (95% Ci, 17%-67%) and 88% (95% Ci, 65%-98%) for reader 1 and 60% (95% Ci, 33%-83%) and 75% (95% Ci, 58%-87%) for reader 2. interobserver agreement between both readers was good (κ = 0.72) for the differentiation between t1 to t2 vs t3 to t4 tumors and moderate (κ = 0.55) for the differentiation of t3cd/t4 tumors.
Serosal the auC for detecting serosal involvement was 0.88 (95% Ci, 0.78-0.98) for reader 1 and 0.72 (95% Ci, 0.51-0.93) for reader 2. the sensitivity and specificity for detecting serosal involvement were 88% (95% Ci, 47%-99%)/74% (95% Ci, 59%-86%) for reader 1 and 68% (95% Ci, 43%-86%)/64% (95% Ci, 46%-79%) for reader 2 (table 2) . interobserver agreement between both readers was good (κ = 0.62).
Nodal Status the sensitivity and specificity for detecting nodal involvement (n0 vs n+) were 47% (95% Ci, 25%-71%)/86% (95% Ci, 70%-95%) for reader 1 and 68% (95% Ci, 43%-86%)/64% (95% Ci, 46%-79%) for reader 2 (table 2) . interobserver agreement between both readers was moderate (κ = 0.60).
Extramural Venous Invasion the auC for detecting emVi was 0.77 for both readers (95% Ci, 0.63-0.91 for reader 1 and 0.63-0.92 for reader 2). Both readers had a high sensitivity of 100% (95% Ci, 60%-100%) and 88% (95% Ci, 47%-99%) and a moderate specificity of 62% (95% Ci, 46%-75%) and 70% (95% Ci, 55%-82%) in detecting emVi. interobserver agreement between both readers was moderate (κ = 0.60).
DISCUSSION
the aim of this study was to evaluate the diagnostic performance of mRi for local staging of patients with colon cancer. our findings show that mRi is able to accurately detect tumors with invasion through the bowel wall. in addition, mRi shows promising results for more recently adopted risk factors, such as serosal involvement and emVi. this means that, together with the already known superior results for the detection of small liver metastasis, mRi could become the most optimal local and distant staging modality for colon cancers. mRi showed accurate results in detecting tumor invasion through the bowel wall, with a high sensitivity and specificity (table 2). the specificity seems especially higher compared with a recent meta-analysis 14 on staging of colon cancer with Ct, where the summary sensitivity and specificity estimates for detecting tumor invasion beyond the bowel wall (t3-t4) with Ct were 90% and 69%; it should be noted, however, that the 95% Cis overlap for both the sensitivity and specificity (table 4). 14, 19-21 the seemingly higher specificity of mRi for colon cancer can probably be explained by the superior soft tissue contrast of mRi. only 1 study is comparable to ours in this category, a very recent study by hunter et al, 19 which demonstrated a lower sensitivity and specificity compared with our results (table 4). this means that more research is needed to define the role of mRi for colon cancer staging. although it is not the focus of our study, DWi was especially useful for locating the colon tumor (as shown in fig. 1a ). the high signal on DWi made it easier to detect small colon tumors.
the detection of t3cd/t4 tumors remains a problem with mRi. in our study, the low sensitivity (40%-60%) indicates that the emD is mainly underestimated and there- Serosa ± = detection of serosal involvement; nodal stage ± = detection of nodal involvement; EMVI ± = detection of extramural vascular involvement. fore t3cd/t4 tumors are understaged, possibly because of microscopic tumor expansion, which is not detectable with mRi. Disappointing results in detecting t3cd/t4 tumors were also found for Ct in a recent meta-analysis, 14 with a higher summary sensitivity but lower specificity estimates compared with our results (table 4) . these low summary estimates might be caused by desmoplastic reaction being interpreted as tumor expansion, resulting in overstaging. a recent study by Rollvén et al, 20 conducted with mRi and Ct and scored by 2 observers, showed a higher sensitivity and specificity for both modalities, with mRi being superior (table 4) . however, this study was relatively small (n = 29) and was carried out by 2 very experienced observers (both dedicated abdominal radiologist with 6 and 18 years of experience). in contrast, the study by hunter et al 19 (which included 55 patients who received mRi only) shows much lower sensitivity and specificity compared with the results presented by Rollvén et al 20 and our study (table 4) . hence, additional research is needed to fully understand the role of imaging for the detection of emD.
TABLE 3. ROC curve results
Tumor stage Reader 1 AUC (95% CI) Reader 2 AUC (95% CI)
according to our results, mRi has a good accuracy in detecting serosal involvement (auC, 0.85-0.88). the ability of mRi to rule out serosal involvement could provide clinicians with valuable information concerning operability and prognosis. Patients with serosal involvement (fig. 1B) have a poorer 5-year survival (24.3%) than those in whom it is absent (55.4%). 22 the mediocre specificity could be explained by desmoplastic reaction involving the serosa or fascia, which may be erroneously interpreted as tumor expansion. to our knowledge, there is no literature about the accuracy of Ct in the detection of serosal involvement as defined in our study.
Results for detecting nodal involvement were mediocre for both readers. according to a recent meta-analysis, 14 Ct shows comparably disappointing results, with summary estimates for sensitivity and specificity of 71% and 67%.
in the pilot study for the foXtRot trial (using Ct), the accuracy was also disappointing, with a good sensitivity of 83% but a low specificity of 44%. 13 Ct and mRi both seem unreliable in the detection of nodal involvement. 19, 20 this fact is also well known in the staging of rectal cancer. 23 although lymph nodes are clearly visible in diffusion-weighted images (as shown in fig. 1C ), this does not necessarily represent metastatic involvement, because the high cellularity in lymph nodes causes a high DWi signal in benign lymph nodes as well. 24, 25 several factors contribute to this low accuracy. lymph node diameter is the most commonly used criterion but is not accurate for assessing lymph node metastasis in colon cancer. 26 moreover, falsenegative results are caused by microscopic metastasis in lymph nodes with a normal diameter, and false-positive results are caused by benign lymph nodes that are enlarged because of inflammation. this is an important diagnostic problem, because distant nodal involvement along the mesenteric arteries may justify a more extensive hemicolectomy. interestingly, new intravenous contrast agents, such as gadofosveset, show promising results for nodal staging in rectal cancer. 27 additional research is warranted, because this may improve the detection of nodal involvement in patients with colon cancer.
in detecting emVi, our results show a very high sensitivity. the ability of mRi to rule out emVi provides clinicians with valuable information, because emVi results in a poorer 5-year survival (25.0%) than if emVi is absent (57.4%). 22 a recent large study, 21 which used Ct to detect emVi, described a low sensitivity and mediocre specificity (table 4) . furthermore, the study by Rollvén et al 20 confirms the superior accuracy of mRi for emVi, whereas the study by hunter et al 19 reports a low sensitivity with a good specificity (table 4) . nonetheless, it appears that mRi is superior in the detection of emVi. the specificity in our study was mediocre, which could be explained by traction on the vessels and/or thrombus formation because of al- This meta-analysis presents the accuracy for staging of colon cancer with CT and included both the studies by Rollvén et al 20 and Dighe et al, 21 except for EMVI, which is given separately.
FIGURE 1.
A, T2-weighted sequence (left) and corresponding b1000 diffusion-weighted images (DWI; right) show a small T2 tumor in the ascending colon (arrow). This small tumor could easily be missed on T2-weighted images. However, it is clearly depicted on DWIs. B, T2-weighted image of a patient with a tumor of the ascending colon (arrow). The tumor grows through the bowel wall. Both readers accurately identified the serosal involvement (black arrowheads), which was nicely depicted with MRI, and the tumor was staged as T4. This was confirmed by histopathology. C, T2-weighted sequence (left) and corresponding b1000 DWI (right) show an example of a small T3 tumor in the ascending colon (arrowhead) and local, enlarged lymph nodes (arrows). Note the conspicuity of these lesions on DWI, aiding in the detection of the tumor and lymph nodes.
tered hemodynamics caused by local inflammation; however, this theory needs to be confirmed by other studies.
Both readers have experience with reading mRi of the abdomen, especially mRi of the rectum; however, reader 1 has a 4-year advantage and is more accurate in the majority of the categories (table 2) . it appears that experience translates into better results; however, it should be noted that this difference is minor in most categories and the interobserver agreement was at least moderate in all of them.
Limitations our study has some limitations. first is the retrospective nature of this study. second, a total number of 55 patients were included in this pilot study. large, multicenter trials are needed to define the role of mRi for dedicated colon staging.
Clinical Impact
Compared with previous literature on Ct, our study shows that mRi appears to perform as well as Ct in local staging, with the added benefit that it has the potential to be more accurate in detecting prognostic factors, such as emVi. an additional important advantage of mRi is its superiority in detecting small liver metastases with the evaluation of the colon tumor in 1 imaging session.
1 the most recent european Registry of Cancer Care or european Cancer audit expert guidelines advise mRi of the liver 28 in the preoperative staging of colorectal cancer. this would mean that the mR sequences for local staging of the colon tumor can be performed in the same mRi session of the liver. this combined approach could result in the most optimal abdominal staging tool for patients with colon cancer. another advantage of this approach is the avoidance of ionizing radiation and nephrotoxic contrast agents.
CONCLUSION
our study shows that mRi has the potential to become a valuable tool in preoperative staging of colon cancer, with results that are comparable with Ct in the detection of important prognostic factors, such as tumor and nodal staging. in addition, mRi appears to have a high sensitivity for additional risk factors, such as serosal involvement and emVi. Combined with its known superiority in detecting liver metastasis, mRi could become the most optimal abdominal staging method for patients with colon cancer. however, because of the limited research on this topic, more research is needed to confirm these promising results.
